Overview of Current Downstream Processing for Modern Viral Vectors-Reference-Cited by-同舟云学术

Overview of Current Downstream Processing for Modern Viral Vectors

Published:2023 Issue: Volume: Page:91-123
ISSN:
Container-title:Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs)
language:
Short-container-title:

Author:

Cashen Paul,McLaughlin Katy

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-28489-2_5

Reference96 articles.

1. Adamson-Small L, Lundgren M, Guterstam P (2020) Scalable and efficient AAV production process with new fibro chromatography technology. Cell Gene Ther Insights 6(8):1249–1262. https://doi.org/10.18609/cgti.2020.138

2. Ajayi OO et al (2022) An updated analysis of viral clearance unit operations for biotechnology manufacturing. Curr Res Biotechnol 4:190–202. https://doi.org/10.1016/j.crbiot.2022.03.002

3. Ausubel LJ et al (2012) Production of CGMP-grade lentiviral vectors. Bioprocess Int 10(2):32–43. https://pubmed.ncbi.nlm.nih.gov/22707919/. Accessed 12 Oct 2022

4. Baghirzade R (2021) Adherent versus suspension based platforms: what is the near future of viral vector manufacturing? Cell Gene Ther Insights 7(11):1365–1371. https://doi.org/10.18609/cgti.2021.180

5. Buclez PO et al (2016) Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system. Mol Ther Methods Clin Dev 3:16035. https://doi.org/10.1038/mtm.2016.35

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of AAV vectors: A review of analytical techniques and critical quality attributes;Molecular Therapy - Methods & Clinical Development;2024-09

2. Affinity chromatography for virus-like particle manufacturing: Challenges, solutions, and perspectives;Journal of Chromatography A;2024-04